Follow the 한국유니온제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한국유니온제약 has published 70 reports. Market capitalisation: €217bn. The latest transaction was filed on 26 May 2026 (Purchase). Among the most active insiders: 안희숙. The full history is accessible without an account.
70
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,868 of 29,063 companies
14.6
score / 100
Value
19
Quality
10
FCF yld-1.7%
Earn yld-43%
EV/EBITDA·
ROE-138%
Gross mgn22%
Net mgn-85%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.